FacebookTwitterRedditEmail

Can Wyeth Fool American Women Twice?

Can Wyeth win back the 40 million Premarin and Prempro users it’s lost since 2002–along with $1 billion a year in profits–with a new menopause drug?

Or will the once-bitten women who have filed more than 5,000 law suits claiming the hormones gave them cancer feel fooled twice?

Pristiq, a serotonin/norepinephrine reuptake inhibitor (SNRI), is a metabolite of Wyeth’s antidepressant Effexor XR–which netted $3.7 billion in 2006–and an unabashed patent extender since Effexor XR goes off patent in 2010.

In February Pristiq was approved by the FDA for the treatment of adults with major depressive disorder but its launch as the first non-hormonal treatment for menopausal symptoms is what Wyeth hopes will fill the Premarin/Prempro/Effexor black hole to the tune of $2 billion a year.

Unfortunately, instead of a green light to market Pristiq for menopause last July, the FDA–also once bitten after Vioxx, Avandia and Vytroin–said to Wyeth not so fast.

Why did two women in the study group taking Pristiq have heart attacks and three need procedures to repair clogged arteries compared with none taking placebo it wanted to know? How can Wyeth assure long term safety when 604 of the 2,158 test subjects took Pristiq for only six months and 318 for a year or more? And what about serious liver complications seen in the studies?

Nor do drug industry insiders on the chatroom cafepharma sound like they’re scooping up Wyeth stock.

“Pristiq is not a good drug by any standard,” wrote one anonymous poster. “We tried to get 100 mg approved as the standard dose. But our patients got so sick that they could care less about the efficacy. They just couldn’t tolerate the drug long enough to see any improvement.”

Like longer than six months?

“No study exists showing any anti-depressant including Pristiq works any better than a placebo for reducing hot flashes, which are subjective anyway and only last a few minutes long at worst,” wrote another anonymous poster. “That is a heavy price to pay to take a heavy duty drug 24/7 for a few minutes of daily relief that a sugar pill also provides. FDA is crazy (or bought) if they allow this unproven drug travesty on the market.”

A third poster predicted women wouldn’t trade, “hot flashes for decreased libido, nausea, increased blood pressure and incredible withdrawal issues,” found with Pristiq. “Women and their physicians are not as gullible as they were back in the Premarin days.”

Even psychiatrist Daniel Carlat who wrote an expose for the New York Times magazine called Dr. Drug Rep last year about his experiences as a Wyeth paid spokesman, is dissing Pristiq.

“Every patient who takes Effexor produces Pristiq in their own body, at no additional charge,” he writes in a blog article called Top 5 Reasons to Forget About Pristiq.

Moreover Wyeth’s own investigator on the major Pristiq trials, Dr. Michael Liebowitz, admits it is “not a revolutionary drug” writes Carlat.

Of course you can’t blame a one trick company that cut its teeth on the Feminine Forever idea that age in women is a disease that needs treating for churning the demographics. Especially as it lays off 1,200 US workers, closes manufacturing plants and fights for its life.

Was it Wyeth’s fault that the hormone “therapy” it pushed for decades actually increases breast cancer by 26 percent, heart attacks by 29 percent, stroke by 41 percent and doubles the risk of blood clots and dementia?

But if US women embrace a major psychiatric drug with possible liver and heart complication side effects after the hormone hoax–manufactured by the same company and at four times the cost of Prempro/Premarin, $4 per day–

Fool me twice–?

MARTHA ROSENBERG is staff cartoonist on the Evanston Roundtable. She can be reached at mrosenberg@evmark.org

 

Your Ad Here
 

 

 

 

 

More articles by:

Martha Rosenberg is an investigative health reporter. She is the author of  Born With A Junk Food Deficiency: How Flaks, Quacks and Hacks Pimp The Public Health (Prometheus).

bernie-the-sandernistas-cover-344x550
Weekend Edition
April 03, 2020
Friday - Sunday
Omar Shaban
Gaza’s New Conflict: COVID-19
Rob Urie
Work, Crisis and Pandemic
John Whitlow
Slumlord Capitalism v. Global Pandemic
Jeffrey St. Clair
Roaming Charges: Strange Things Happening Every Day
Jonathan Cook
The Bigger Picture is Hiding Behind a Virus
Paul Street
Silver Linings Amidst the Capitalist Coronavirus Crisis
Evaggelos Vallianatos
The Control of Nature
Louis Proyect
COVID-19 and the “Just-in-Time” Supply Chain: Why Hospitals Ran Out of Ventilators and Grocery Stores Ran Out of Toilet Paper
Kathleen Wallace
The Highly Contagious Idea
Kenneth Good
The Apartheid Wars: Non-Accountability and Freedom for Perpetrators.
Andrew Levine
Democracy in America: Sorry, But You Can’t Get There from Here.
Ramzy Baroud
Tunisia Leads the Way: New Report Exposes Israel’s False Democracy
David Rosen
Coronavirus and the State-of-Emergency Pandemic
Matthew Stevenson
Will Trump Cancel the Election? Will the Democrats Dump Joe?
Ron Jacobs
Seattle—Anti-Capitalist Hotbed
Michael T. Klare
Avenger Planet: Is the COVID-19 Pandemic Mother Nature’s Response to Human Transgression?
Jack Rasmus
COVID-19 and the Forgotten Working Class
Werner Lange
The Madness of More Nukes and Less Rights in Pandemic Times
J.P. Linstroth
Why a Race is Not a Virus and a Virus is Not a Race
John Feffer
We Need a Coronavirus Truce
Thomas S. Harrington
“New Corona Cases”: the Ultimate Floating Signifier
Victor Grossman
Corona and What Then?
Katie Fite
Permanent Pandemic on Public Lands: Welfare Sheep Ranchers and Their Enablers Hold the West’s Bighorns Hostage
Patrick Bond
Covid-19 Attacks the Down-and-Out in Ultra-Unequal South Africa
Eve Ottenberg
Capitalism vs. Humanity
Nicky Reid
Fear and Loathing in Coronaville Volume 2: Panic On the Streets of Tehran
Jonas Ecke
Would Dying for the Economy Help Anybody?
Jeff Mackler
Capitalism is the Virus!
Andrew Moss
Incarceration, Detention, and Covid-19
Farzana Versey
Prayers, Piffle and Privation in the Time of Pandemic
Will Solomon
In the New Dystopia
Dean Baker
The Relative Generosity of the Economic Rescue Package: Boeing vs. Public Broadcasting
Dr. Leo Lopez, III
We Need a Lot More Transparency From the CDC
Kollibri terre Sonnenblume
Reflections on a Glass of Homemade Cider
Rashid Nuri
Homegrown Crisis Response: Who Grows Your Food?
Mark Luskus
Worst Case Scenario: Healthcare Workers Need Masks, ASAP
Volker Franke
The Virus That May Bring us Together
Mitchell Zimmerman
A Q & A on the GOP’s Call for Elder Sacrifice
Olfat al-Kurd
COVID-19 Could Be Catastrophic for Us: Notes From Gaza
Eileen Appelbaum - Roesmary Batt
Hospital Bailouts Begin…for Those Owned by Private Equity Firms
Nabri Ginwa
Carcinogens
Jill Richardson
Efficiency vs. Resilience
Lee Ballinger
Eddie Van Halen and the Future of Humanity
David Yearsley
Beset by Bach
Robert Koehler
Developing a Vaccine Against War
FacebookTwitterRedditEmail